These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22649373)

  • 1. Approach to lipid screening as a risk marker for cardiovascular disease in pediatric patients with diabetes.
    Law JR; Patel S; Spagnoli A
    Front Endocrinol (Lausanne); 2011; 2():47. PubMed ID: 22649373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care.
    Hartz JC; de Ferranti S; Gidding S
    J Endocr Soc; 2018 Jun; 2(6):497-512. PubMed ID: 29850649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
    Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
    Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current state of dyslipidemia in Korean children and adolescents and its management in clinical practice.
    Lim JS
    Ann Pediatr Endocrinol Metab; 2013 Mar; 18(1):1-8. PubMed ID: 24904843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes and lipid metabolism.
    Athyros VG; Doumas M; Imprialos KP; Stavropoulos K; Georgianou E; Katsimardou A; Karagiannis A
    Hormones (Athens); 2018 Mar; 17(1):61-67. PubMed ID: 29858856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARY
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M; Zangeneh F; Bush MA
    Endocr Pract; 2017 Apr; 23(4):479-497. PubMed ID: 28156151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premature death and risk of cardiovascular disease in young-onset diabetes: a 23-year follow-up of the Da Qing Diabetes Study.
    Hui Y; Wang J; An Y; Gong Q; Li H; Zhang B; Shuai Y; Chen Y; Hu Y; Li G
    Endocrine; 2019 Jul; 65(1):46-52. PubMed ID: 31001730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiometabolic risk assessment: an approach to the prevention of cardiovascular disease and diabetes mellitus.
    Vasudevan AR; Ballantyne CM
    Clin Cornerstone; 2005; 7(2-3):7-16. PubMed ID: 16473256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of High Intensity Statin Therapy in the Treatment of Diabetic Dyslipidemia in Patients with Coronary Artery Disease.
    Vavlukis M; Kedev S
    Curr Pharm Des; 2018; 24(4):427-441. PubMed ID: 29283060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid control in patients with diabetes mellitus.
    Betteridge DJ
    Nat Rev Cardiol; 2011 May; 8(5):278-90. PubMed ID: 21403658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of co-existing diabetes mellitus and dyslipidemia: defining the role of thiazolidinediones.
    Florkowski CM
    Am J Cardiovasc Drugs; 2002; 2(1):15-21. PubMed ID: 14727995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on screening, etiology, and treatment of dyslipidemia in children.
    Bamba V
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3093-102. PubMed ID: 24848708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving Long-Term Outcomes of Youth With Lipid Abnormalities-Expanding the Role of Pediatric Endocrinologists.
    Ashraf AP; Kohn B; Wilson DP
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4421-4426. PubMed ID: 31120509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the inflammatory profiles for incidence of diabetes mellitus and cardiovascular diseases: a prospective study exploring the 'common soil' hypothesis.
    Bao X; Borné Y; Johnson L; Muhammad IF; Persson M; Niu K; Engström G
    Cardiovasc Diabetol; 2018 Jun; 17(1):87. PubMed ID: 29895294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood antecedents to adult cardiovascular disease.
    Halfon N; Verhoef PA; Kuo AA
    Pediatr Rev; 2012 Feb; 33(2):51-60; quiz 61. PubMed ID: 22301031
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.